Related Experiment Video
Updated: Jun 13, 2026
07:39
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Mechanical circulatory support for bridge to decision: which device and when to decide
Elizabeth A Ziemba1, Ranjit John
1Department of Surgery, University of Minnesota, Minneapolis, Minnesota 55455, USA.
Journal of Cardiac Surgery
|April 24, 2010
Summary
Temporary circulatory support is crucial for patients with acute heart failure and refractory cardiogenic shock. This review explores available devices and the University of Minnesota
Area of Science:
- Cardiology
- Medical Devices
- Critical Care Medicine
Background:
- Acute heart failure management has advanced, yet outcomes for refractory acute cardiogenic shock remain poor.
- Temporary circulatory support is essential for improving outcomes in these critically ill patients.
- Optimal device selection, support duration, and bridging strategies require further clarification.
Purpose of the Study:
- To review current temporary circulatory support devices for acute cardiogenic shock.
- To discuss the University of Minnesota's experience with the Levitronix CentriMag system.
Main Methods:
- Literature review of available temporary circulatory support devices.
- Summary of clinical experience with the Levitronix CentriMag system.
Main Results:
- Several circulatory support options exist, including ventricular assist devices and extracorporeal membrane oxygenation.
- The Levitronix CentriMag system is a viable option for temporary circulatory support.
Conclusions:
- Wider application of temporary circulatory support is indicated for refractory acute cardiogenic shock.
- Further research is needed to define optimal device use, duration, and bridging strategies.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...